Schizophrenics On Medication At An Increased Risk For Developing Diabetes

by Medindia Content Team on  January 10, 2005 at 2:28 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Schizophrenics On Medication At An Increased Risk For Developing Diabetes
A recent study shows , schizophrenics treated with clozapine and olanzapine may be at an increased risk for developing type 2 diabetes. Patients taking these antipsychotic agents resisted insulin and had impairment of glucose effectiveness compared with patients taking another drug under study.

Researchers evaluated 36 non-obese people with schizophrenia or schizoaffective disorder who were treated with clozapine (Clozaril), olanzapine (Zyprexa, Zydis), or risperidone (Risperdal). The participants followed a certain diet to maintain body weight and fasted before having a glucose tolerance test. Schizophrenics were found to have a much shorter life expectancy than the general population attributable to many factors, including cardiovascular disease.

Thus researchers conclude, that psychiatrists and primary care professionals should be aware that patients treated with clozapine and olanzapine may be at increased risk for insulin resistance, even if not obese and patients treated with these agents should be routinely screened and counseled to reduce risk, and provided early interventions.

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Diabetic Retinopathy Diabetes Diabetic Diet Diabetes - Essentials Insulin Delivery Devices Diabetes and Exercise Stress Relief Through Alternative Medicine Stress and the Gender Divide Silent Killer Diseases Diabetes Facts 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...